Latest stories on ZYME
A Post Acquisition Look At Zymeworks
Seeking Alpha63 · neutralm&a
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
Business Insider50 · neutralgeneral
Truist Remains Bullish on Zymeworks (ZYME) – Here’s Why
Yahoo Top61 · neutralanalyst
Here's Why Zymeworks Inc. Paid $929M For Theravance Biopharma
Seeking Alpha63 · neutralm&a
Is Zymeworks Inc. (ZYME) Stock an Undervalued Biotech Opportunity With Oncology Growth Ahead?
Yahoo Top56 · neutralanalyst
Zymeworks Inc. (ZYME) M&A Call - Slideshow
Seeking Alpha50 · neutralm&a
Zymeworks agrees to buy Theravance Biopharma for $929m
Yahoo Finance63 · neutralm&a
Zymeworks Inc. (ZYME) M&A Call Transcript
Seeking Alpha50 · neutralm&a
Zymeworks To Buy Theravance Biopharma In $929M Deal – A Look At What This Deal Means For TBPH Shareholders
Stocktwits News58 · neutralm&a
Zymeworks to Acquire Theravance in Strategic Merger
TipRanks62 · neutralm&a
Zymeworks Inc. (ZYME) files 8-K
SEC 8-K50 · neutralgeneral
Theravance Biopharma to be Acquired by Zymeworks
TipRanks62 · neutralm&a
M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B
TipRanks63 · neutralm&a
Zymeworks to pay $17/share for Theravance Biopharma in $929M deal
Seeking Alpha63 · neutralm&a
Zymeworks to Acquire Theravance Biopharma, Inc.
GlobeNewswire63 · neutralm&a
Zymeworks to Acquire Theravance Biopharma, Inc. | ZYME Stock News
StockTitan63 · neutralm&a
Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery | ZYME Stock News
StockTitan63 · neutralproduct/pr
Zymeworks: Royalty-Backed Biotech Flywheel With Underappreciated ADC Optionality
Seeking Alpha63 · neutralproduct/pr
Zymeworks Earnings Call Balances Promise and Risk
TipRanks56 · neutralearnings